Notable Labs Ltd (NTBL)

0.950 -0.025 (-2.56%)
Real-time Cboe USD Disclaimer

Notable Labs Ltd Company Profile

Sector
Healthcare
Employees
16
Equity Type
ORD
Notable Labs, Ltd., a clinical-stage platform therapeutics company, engages in developing predictive precision medicines for patients with cancer. The company, through its proprietary Predictive Precision Medicines Platform (PPMP), bio-simulates a cancer treatment and predicts, whether or not the patient will clinically respond to their actual treatment. Its PPMP is designed to identify and select clinically responsive patients prior to their treatment and thus fast-track therapeutic development in this patient population. The company’s pipeline includes Volasertib, a potent Polo-like kinase 1 (PLK-1) inhibitor to induce cell cycle arrest and apoptosis in various cancer cells.; and Fosciclopirox, a pro-drug of ciclopirox for AML. Notable Labs, Ltd. was incorporated in 2014 and is headquartered in Foster City, California.
Contact Information
Address
Foster City,94404 United States
Phone
415-851-2410
Fax
-
Top Executives
Name
Age
Since
Title
Thomas A. Bock 59 2020 CEO & Director
Tuomo Patsi 60 2023 Independent Chairman
Thomas I. H. Dubin 62 2023 Independent External Director
Michael Yehuda Rice 58 0000 Independent Director
Michele Galen 67 2023 Independent Director
Peter Feinberg 62 2023 Independent Director
Thomas Graney 59 2023 Independent External Director
Clear All
0Selected
Please try another search

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.